Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy.
about
The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapyStructure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.ATP-binding casette transporter expression in acute myeloid leukemia: association with in vitro cytotoxicity and prognostic markers.Predicting Chemotherapy Resistance in AML.Impact of ABC single nucleotide polymorphisms upon the efficacy and toxicity of induction chemotherapy in acute myeloid leukemia.
P2860
Q141K polymorphism of ABCG2 protein is associated with poor prognosis in adult acute myeloid leukemia treated with idarubicin-based chemotherapy.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Q141K polymorphism of ABCG2 pr ...... idarubicin-based chemotherapy.
@en
Q141K polymorphism of ABCG2 pr ...... idarubicin-based chemotherapy.
@nl
type
label
Q141K polymorphism of ABCG2 pr ...... idarubicin-based chemotherapy.
@en
Q141K polymorphism of ABCG2 pr ...... idarubicin-based chemotherapy.
@nl
prefLabel
Q141K polymorphism of ABCG2 pr ...... idarubicin-based chemotherapy.
@en
Q141K polymorphism of ABCG2 pr ...... idarubicin-based chemotherapy.
@nl
P2093
P2860
P1433
P1476
Q141K polymorphism of ABCG2 pr ...... idarubicin-based chemotherapy.
@en
P2093
Alessandra Franzoni
Dora Fabbro
Giuseppe Damante
Renato Fanin
P2860
P356
10.3324/HAEMATOL.2012.075895
P577
2012-10-12T00:00:00Z